thisismyself Posted - 4 hours ago

$AIM several minutes ago, something highly unusual happened. My phone had been in my back pocket. The phone was on. When I pulled my phone out of my back pocket, I saw the phone logo, which is only seen after the phone has been restarted (it's the screen that comes up after it Powers off and restarts) But I did not restart my phone. After the logo came up, instead of transitioning to the main screen with all of the icons, the screen went dark for several second at least, and then the logo came back on the screen, again for several seconds at least, and then it transitioned to the regular icons. Whenever I restart my phone, I don't recall ever seeing a dark screen appear like that after the logo screen comes up

Mikep9959 Posted - 4 hours ago

$AIM tonight at 8pm will be the reveal.. I think it important for me to write about all the evidence as I see it.. Then see if anyone agrees... I think it's good stuff... Again please review the ceo corner for recent 2 segments.... Both for pancreatic cancer

thisismyself Posted - 21 hours ago

$AIM today I had a vision that appeared to say: Prepare for the worst

Mikep9959 Posted - 1 day ago

$AIM imo we have missed something significant as it relates to our pancreatic Studies.. The 270 study is ampligen only for patients who have advanced but localized cancer The duripanc study is for patients whose cancer has spread and metastasized... It all doesn't make sense to me.. I will be giving some thoughts Sunday evening... Please listen to the corresponding ceo corners on the 2 studies... Maybe we can make it make sense... My conclusion may mean this is really big...

ultimatebastos Posted - 1 day ago

$AIM we need a roaring kitty....

Jasonbush Posted - 1 day ago

$AIM I was thinking about the call from Thursday. They said in three months time they will have biomarkers of who Ampligen works on for long Covid. They get that information, the company becomes way more valuable, if the results are good.

Jaortiz Posted - 1 day ago

$AIM https://meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/search?q=rintatolimod

Jasonbush Posted - 1 day ago

$AIM https://x.com/mecfsiscfsnotme/status/1790601581919903908?s=46

Jasonbush Posted - 1 day ago

$AIM well this is something https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-08077-x

jalal81 Posted - 1 day ago

$AIM I’m accumulating, know what you own

locs Posted - 1 day ago

$AIM just a final random thought before the weekend....I can only imagine another company wanting an opportunity... BMS, Ely Lily, Novartis, Amgen, Gilead, Sanofi, GSK, Bayer. I haven't created enough time to review how Ampligen could be beneficial for them, outside of them generally pursuing oncology, but they are just more availability outside of the expected Merck and Astrazeneca.

jonjonson Posted - 1 day ago

$AIM Tik, tok.... https://aimimmuno.com/hemispherx-biopharma-exploring-possible-research-programs-in-zika-virus-modeled-on-a-prior-alferon-n-clinical-trial-on-closely-related-flavivirus-west-nile/

jonjonson Posted - 1 day ago

$AIM Things are starting to sound might "Mercky" around here.... ROTFLMAO.....

Mikep9959 Posted - 2 days ago

$AIM this is not real it's a made up scenario and you must vote yes or no.. Tom had to take an emergency leave and I was designated temporary ceo... Merck says they can't do a deal until 2025. But AZ. has approached with a potential deal..

Everydayisasaturday Posted - 2 days ago

$AIM

ultimatebastos Posted - 2 days ago

$AIM https://www.scientificamerican.com/article/revolutionary-genetics-research-shows-rna-may-rule-our-genome/

micklemas Posted - 2 days ago

$AIM momo2021 still doing his pencil dck bully schtick I see ✏️✏️✏️✏️ do better

Mikep9959 Posted - 2 days ago

$AIM that cup and handle stock Swin up again...at least 10 more bucks

Mikep9959 Posted - 2 days ago

$AIM one way I have read you can evaluate a drug is by one year peak sales... Currently thats 29 billion I believe Ampligen will have sales of at least 29 billion peak year Is 29 billion too much to ask?..

momo2021 Posted - 2 days ago

$AIM RS and dilution on tap its no secret big mouth bul mar who has never posted a winner ever in over 11 yrs blames it on the shorts why he is down 99% but dumb dumb this turd is at 39 cents cause they proven nothing meanwhile 50m outstanding and only 400k shorts 🤡

Mikep9959 Posted - 2 days ago

$AIM To strengthen its market position and portfolio, Merck is exploring subcutaneous (under-the-skin shot) formulations of Keytruda, mergers and acquisitions in the $1 billion to $15 billion range and potential partners," Gaur said. 10 to 15B sounds about right for the value ampligen could bring to merck..

h2oMark Posted - 2 days ago

$AIM Bullish AIM Bullish AIM Bullish AIM Folks, peeps, friends, Longs ... Ampligen works. Oh, and in case you didn't know - Ampligen works ! We're just waiting for the T's to be crossed, the I's to be dotted, and the ink to dry on the contract. Buy a few more shares while it's still affordable.

Mikep9959 Posted - 2 days ago

$AIM what can 5 billion buy big pharma??? April 10 Status: Pending; expected closing Q2 Deal value: $4.9 billion Vertex Pharmaceuticals said that it would acquire clinical-stage immunotherapy company Alpine Immune Sciences in what is the largest biopharma M&A announced in two months. Vertex will pay $65 per share in an all-cash transaction to augment its pipeline of candidates for autoimmune and inflammatory diseases. Alpine’s lead asset povetacicept, a dual antagonist of the BAFF and APRIL cytokines, is currently in a Phase II study in IgA nephropathy, for which it has shown best-in-class potential, according to Vertex. So how does this compare to ampligen.. Not well at all Please start the bidding for ampligen rights at 5 billion minimum

Mikep9959 Posted - 2 days ago

$AIM back in another lifetime I used to do Sunday science sessions... I plan to do one of those Sunday evening... I think we have missed a massive opportunity that only struck metastatic couple weeks ago... It has to do with AZ and our deal with them over the planned durapanc study.. We have missed a pretty obvious opportunity with AZ and our deal with them If anyone has any idea what opportunity we've missed ... I will spill my guts now... Otherwise you will have to wait until Sunday so I can do some research... How could we miss this great opportunity.?? Lol

TheLionofwallstreet Posted - 2 days ago

$AIM I don't know about you guys but been using aim as my penny bank. Adding gains from other plays here. One day it will pop 🎉

PercyFinn Posted - 3 days ago

$AIM AIM insiders are buying, institutions do too. It seems like everybody is waiting for a pop.

Packmentality Posted - 3 days ago

$AIM Institutional buying… A bit of buying the last few days. Morgan Stanley and others… https://fintel.io/sob/us/aim

momo2021 Posted - 3 days ago

$AIM RS and dilution thanks bulmar who pumped this for 10 yrs blamed it on naked shorts and likes and all we get is 99% losses not even a tshirt

Everydayisasaturday Posted - 3 days ago

$AIM Checked out https://azenova.com/ website. Just reading Azenova's services offered, it seems we are in good hands. The specifics of their skill set and the timing of their connection with AIM, tells me we are closer to the end of waiting patiently. Tom would not have contracted with Azenova if AIM were not moving closer to a deal of some sort.

Mikep9959 Posted - 3 days ago

$AIM there is a progression that usually occurs in drugs used for cancer treatment especially combo drugs... First they are tested as a single drug... Second they are tested in combination.. Like ampligen and keytruda The third phase and the most challenging is their use when cancer has spread to other locations... Based on how ampligen works I expect more studies where the cancer has metastasized I believe our first study like this will be pancreatic cancer It's considered stage 4 cancer when this occurs Please follow if you don't already....tia